BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Business

  Vertex Teases Launch of Landmark CRISPR Therapy

  Vertex Pharmaceuticals is marching toward the launch of exa-cel with a lot of confidence, per its full-year 2022 presentation.

  February 9, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• 

  AbbVie Braces for Impact as Humira Biosimilars Hit the Market

  AbbVie has officially reached the Humira cliff, and 2023 estimates are feeling the effects. The Illinois-based biopharma shared its Q4 and full-year 2022 results Thursday morning.

  February 9, 2023

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Another IL-12 Candidate Bites the Dust as AstraZeneca Shifts Focus

  AstraZeneca announced it is making significant cuts from its pipeline in an attempt to realign its priorities and recover from waning COVID-19 drug sales.

  February 9, 2023

   · 

  2 min read

   · 

  Rosemary Scott
• 

  Business

  Bayer Caves to Investor Pressure, Picks Roche Vet as CEO

  Amid mounting pressure from investors and shareholders, Bayer’s supervisory board unanimously appointed outsider Bill Anderson as its new CEO.

  February 9, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• Fastox awarded Innovation of the Year at the 2023 IMCAS World Congress.

  Swiss biotech Fastox Pharma has been awarded “Innovation of the Year” at the IMCAS conference in Paris from January 26 to 28, 2023.

  February 9, 2023

   · 

  2 min read
• Drug Development

  Prolong Pharmaceuticals Announces Presentation of Phase 1 Data from HEMERA-1 Clinical Study of PP-007 in Patients with Acute Ischemic Stroke at the Late-Breaking Science Session, ISC 2023

  Prolong Pharmaceuticals announced that preliminary data from the recently completed Phase 1 clinical study of PP-007 in acute ischemic stroke patients will be presented in the Late-Breaking Science session during ISC 2023 in Dallas, TX and in the forthcoming PAIRS conference in Dubai.

  February 9, 2023

   · 

  3 min read
• Business

  RadNet, Inc. Announces Date of its Fourth Quarter 2022 Financial Results Conference Call

  RadNet, Inc. announced that it will host a conference call to discuss its fourth quarter 2022 financial results on Tuesday, February 28, 2022 at 7:30 a.m. Pacific Time.

  February 9, 2023

   · 

  1 min read
• Business

  RQ Bio Strengthens Board with Industry-leading Infectious Disease Experts Joining as Non-Executive Directors

  RQ Bio is scaling up at speed, with the appointment of Non-Executive Directors, Dr W. Ripley (“Rip”) Ballou and Dr Jacques Cholat to its Board of Directors.

  February 9, 2023

   · 

  5 min read
• Theravance Biopharma to Participate in an Upcoming February 2023 Investor Conference

  Theravance Biopharma, Inc. will participate in a Fireside Chat at the SVB Securities Global Biopharma Conference on Wednesday, February 15 at 8:00 am ET.

  February 9, 2023

   · 

  1 min read
• BioForest

  Madorra announces publication of positive 12-week and 12-month Pilot 1 Randomized Controlled Trial Results

  Madorra announces publication of positive Pilot 1 randomized controlled trial results for the company’s non-invasive, home-use device for women experiencing moderate to severe vulvovaginal atrophy, a component of genitourinary syndrome of menopause.

  February 9, 2023

   · 

  6 min read